Literature DB >> 6191278

Solubilization and immune-detection of beta-galactosidase hybrid proteins carrying foreign antigenic determinants.

K K Stanley.   

Abstract

Three DNA fragments representing almost the entire E1 gene of Semliki Forest virus (SFV) were inserted into a cro-lacZ expression vector by oligo dC.oligo dG tailing. Fragments inserted close to the 5' end of the lacZ gene gave rise to hybrid proteins which were rapidly degraded. Insertion of the same fragments at the 3' end, however, resulted in the synthesis of stable hybrid proteins which precipitated in an insoluble form within the bacteria. Insufficient hybrid protein was soluble to allow detection by immunoradiometric assay. Colonies grown on nitrocellulose filters, however, could be solubilized in SDS and subsequently renatured such that antibodies raised against the intact or SDS-denatured E1 protein cross-reacted with the hybrid proteins in a high percentage of colonies. This model system demonstrates a simple procedure for identifying DNA exon fragments by the immunological detection of expressed hybrid proteins.

Entities:  

Mesh:

Substances:

Year:  1983        PMID: 6191278      PMCID: PMC326026          DOI: 10.1093/nar/11.12.4077

Source DB:  PubMed          Journal:  Nucleic Acids Res        ISSN: 0305-1048            Impact factor:   16.971


  20 in total

1.  Immunological screening method to detect specific translation products.

Authors:  S Broome; W Gilbert
Journal:  Proc Natl Acad Sci U S A       Date:  1978-06       Impact factor: 11.205

2.  Lac repressor can be fused to beta-galactosidase.

Authors:  B Müller-Hill; J Kania
Journal:  Nature       Date:  1974-06-07       Impact factor: 49.962

3.  Selection of specific clones from colony banks by screening with radioactive antibody.

Authors:  L Clarke; R Hitzeman; J Carbon
Journal:  Methods Enzymol       Date:  1979       Impact factor: 1.600

4.  A sensitive radioimmunoassay for detecting products translated from cloned DNA fragments.

Authors:  H A Erlich; S N Cohen; H O McDevitt
Journal:  Cell       Date:  1978-04       Impact factor: 41.582

5.  Cleavage of structural proteins during the assembly of the head of bacteriophage T4.

Authors:  U K Laemmli
Journal:  Nature       Date:  1970-08-15       Impact factor: 49.962

6.  Expression in Escherichia coli of chemically synthesized genes for human insulin.

Authors:  D V Goeddel; D G Kleid; F Bolivar; H L Heyneker; D G Yansura; R Crea; T Hirose; A Kraszewski; K Itakura; A D Riggs
Journal:  Proc Natl Acad Sci U S A       Date:  1979-01       Impact factor: 11.205

7.  Expression of cloned beta-endorphin gene sequences by Escherichia coli.

Authors:  J Shine; I Fettes; N C Lan; J L Roberts; J D Baxter
Journal:  Nature       Date:  1980-06-12       Impact factor: 49.962

Review 8.  Antibodies to chemically synthesized peptides predicted from DNA sequences as probes of gene expression.

Authors:  R A Lerner; J G Sutcliffe; T M Shinnick
Journal:  Cell       Date:  1981-02       Impact factor: 41.582

9.  Construction of plasmid cloning vehicles that promote gene expression from the bacteriophage lambda pL promoter.

Authors:  H U Bernard; E Remaut; M V Hershfield; H K Das; D R Helinski; C Yanofsky; N Franklin
Journal:  Gene       Date:  1979-01       Impact factor: 3.688

10.  A technique for ultracryotomy of cell suspensions and tissues.

Authors:  K T Tokuyasu
Journal:  J Cell Biol       Date:  1973-05       Impact factor: 10.539

View more
  43 in total

1.  Mapping of conformational epitopes of monoclonal antibodies against Escherichia coli penicillin-binding protein 1B (PBP 1B) by means of hybrid protein analysis: implications for the tertiary structure of PBP 1B.

Authors:  T Den Blaauwen; E Pas; A Edelman; B G Spratt; N Nanninga
Journal:  J Bacteriol       Date:  1990-12       Impact factor: 3.490

2.  The Saccharomyces cerevisiae genes (CMP1 and CMP2) encoding calmodulin-binding proteins homologous to the catalytic subunit of mammalian protein phosphatase 2B.

Authors:  Y Liu; S Ishii; M Tokai; H Tsutsumi; O Ohki; R Akada; K Tanaka; E Tsuchiya; S Fukui; T Miyakawa
Journal:  Mol Gen Genet       Date:  1991-05

3.  Deletion of an additional domain located between SXXK and SXN active-site fingerprints in penicillin-binding protein 4 from Escherichia coli.

Authors:  H Mottl; P Nieland; G de Kort; J J Wierenga; W Keck
Journal:  J Bacteriol       Date:  1992-05       Impact factor: 3.490

4.  Characterization and identification of early proteins in Chlamydia trachomatis serovar L2 by two-dimensional gel electrophoresis.

Authors:  A G Lundemose; S Birkelund; P M Larsen; S J Fey; G Christiansen
Journal:  Infect Immun       Date:  1990-08       Impact factor: 3.441

5.  Optimized heterologous expression of the human zinc enzyme glyoxalase I.

Authors:  M Ridderström; B Mannervik
Journal:  Biochem J       Date:  1996-03-01       Impact factor: 3.857

6.  Cloning of a human liver microsomal UDP-glucuronosyltransferase cDNA.

Authors:  M R Jackson; L R McCarthy; D Harding; S Wilson; M W Coughtrie; B Burchell
Journal:  Biochem J       Date:  1987-03-01       Impact factor: 3.857

7.  Cloning and characterization of the gene coding for cytoplasmic seryl-tRNA synthetase from Saccharomyces cerevisiae.

Authors:  I Weygand-Durasevic; D Johnson-Burke; D Söll
Journal:  Nucleic Acids Res       Date:  1987-03-11       Impact factor: 16.971

8.  The primary structure of human hemopexin deduced from cDNA sequence: evidence for internal, repeating homology.

Authors:  F Altruda; V Poli; G Restagno; P Argos; R Cortese; L Silengo
Journal:  Nucleic Acids Res       Date:  1985-06-11       Impact factor: 16.971

9.  A 135-kilodalton surface antigen of Mycoplasma hominis PG21 contains multiple directly repeated sequences.

Authors:  S A Ladefoged; S Birkelund; S Hauge; B Brock; L T Jensen; G Christiansen
Journal:  Infect Immun       Date:  1995-01       Impact factor: 3.441

10.  Characterization of native and recombinant 75-kilodalton immunogens from Chlamydia trachomatis serovar L2.

Authors:  S Birkelund; A G Lundemose; G Christiansen
Journal:  Infect Immun       Date:  1989-09       Impact factor: 3.441

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.